Pliant Therapeutics
PLRX • NASDAQ
Pliant Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bernard Coulie, with a market cap of $83.6M.
Market Cap$83.6M
Employees158.0
CEOBernard Coulie
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Pliant Therapeutics FAQ
Common questions about Pliant Therapeutics
Pliant Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026.
Pliant Therapeutics has approximately 158 employees.